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Synthetic Lethality and Clonogenic Assay
On the cellular level, cancer cells are able to divide by repair DNA damage through DNA repair pathways. In order 
to survive, cancer cells utilize a certain repair pathway and rely on it to replicate. The idea of synthetic lethality is 
that the repair pathway can be inhibited, therefore causing cancer cell death3. The objective of this project is to 
sensitize cells, specifically cancer cells, to radiation by utilizing the concept of synthetic lethality.
Results: Nanoparticles
The maximum yield of Doxorubicin achieved in the NPs was 
about 10uM. This is significantly higher than in our previous 
research, and did not produce nanoparticles that were as large 
either. Fig. 5 and Fig. 6 show the effects of two different 
conditions that were varied, concentration of poly(vinyl alcohol), 
or PVA, and amount of PLGA. Lower concentrations of PVA 
produced more favorable NPs (Fig. 5). Fig. 6 shows 50mg of 
PLGA producing much less favorable NPs than other amounts, 
which does not make sense, so it would be worth running this trial 
again to determine if it can produce a balance of high drug loading 
and small enough diameter. We believe using more PLGA 
produces more drug loading in the NPs, but compromises the size.
Nanoparticles and Optimization
To accomplish the delivery of DNA repair pathway inhibiting drugs, we use nanoparticles (NPs). This 
serves to transport the drugs to cancer cells without damaging healthy tissue so that destroying the tumors 
with radiation will be more effective. We used poly(lactic-co-glycolic acid), or PLGA, nanoparticles due to 
their safety and simple preparation methods. We must optimize the NPs for size and drug loading to 
increase effectiveness. The NPs must be less than 200nm in diameter so they will not be filtered out by the 
body, and increasing the drug loading makes them more effective and less expensive. We used 
Doxorubicin, an established cancer drug, as a model drug due to its fluorescent properties. Optimization of 
the NPs included variation of sonication/stirring, organic and aqueous phases, amount of PLGA, and 
amount of Doxorubicin. A single emulsion preparation method was used due to more success in our 
previous experiments than a double emulsion. This method uses differences in polarity between the phases 
to form layers and force the drug into NPs through sonication (Fig. 4).
Results: Drugs
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Discussion
The drug AZD2461 works by blocking the cancer’s cells repair pathway. When a single strand break occurs in the DNA, PARP is recruited to repair the DNA break. When AZD2461 is present, PARP is blocked and the DNA cannot be 
repaired. The data shows that the blocking of this repair pathway makes the cells easier to kill with radiation. The presence of a drug will ideally make less radiation more effective. The combination of AZD2461 and radiation treatment 
caused a decrease in cell survival at low concentrations of hydrogen peroxide and all concentrations of Bleomycin. The next step in this research is to incorporate drug combinations to determine what treatment best sensitizes cells to 
radiation treatment. Having produced NPs with significant drug loading, the next step will be to test the Doxorubicin-loaded NPs on glioblastoma cells, as well as incorporate DNA repair pathway inhibiting drugs into NPs.
Figure 2: Pictured is a set of 
Methylene Blue stained plates 
which were utilized to 
determine plating efficiency 
and the ideal concentration of 
cells to be plated for the 
clonogenic assay. The well 
concentration of U118 cells 
per well is labeled in the 
image.
Figure 1: a) Hydrogen peroxide and Bleomycin 
treatments generate single-strand and double-strand 
breaks which mimic the DNA damage caused by 
ionizing radiation. b) AZD2461 inhibits the repair of 
single-stranded breaks by binding to and inhibiting the 
nuclear enzyme, poly(ADP-ribose) polymerase (PARP). 
This protein plays a significant role in DNA repair2.
The clonogenic assay detects all cells that have the ability to form a 
significantly sized colony. This is a standard assay for testing replicative 
cell death because it is able to give a precise cell kill measurement. This 
assay confirms that DNA damage has occurred and allows for the drug to 
be assessed in terms of success of blocking the repair pathway. After 
treatment with the drug and the DNA damage agent, the cells are allowed 
to grow for 10 days. The growth time allows the replicative ability of the 
cells to be measured. The cells are dyed with methylene blue (Fig. 2) and 
the colonies over 50 cells are counted.
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Figure 3: To mimic the damaging effects of 
radiation, cells were subjected to Hydrogen 
Peroxide and Bleomycin. DNA damage 
methods can be compared in the figures to the 
left. On the y-axis is the log of percent 
survival, or the cells ability to replicate and 
create sizable colonies after DNA damage. 
Each graph shows a variety of concentrations 
of the chemical that provides DNA damage. 
The curves compare one set of cells that was 
first treated with 10 uM of the DNA repair 
pathway drug AZD 2461.
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Figure 4: An example of an oil in water emulsion 
technique similar to what we used our 
experiments.
https://www.omicsonline.org/articles-
images/2157-7013-S5-001-g001.gif
Figure 5: PLGA NPs 
demonstrating effects of 
varying w phase PVA 
concentration on diameter 
and drug loading under the 
conditions of sonication for 
3.5min at 75% amplitude, 
stirring for 1.25hr at 900rpm, 
and o phase containing 
100µL of 100µM 
Doxorubicin, 30mg PLGA, 
2.5mL dichloromethane, and 
0.5mL methanol.
Figure 6: PLGA NPs 
depicting effects of varying 
amounts of PLGA on 
diameter and drug loading 
under the conditions of 
sonication for 3.5min at 
75% amplitude, stirring for 
1.25hr at 900rpm, w phase 
5mL of 2% PVA, and o 
phase containing 100µL of 
100µM Doxorubicin, 30mg 
PLGA, 2.5mL 
dichloromethane, and 0.5mL 
methanol.
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